118 related articles for article (PubMed ID: 7273031)
1. 5-FU, methotrexate, and mitomycin in advanced colorectal adenocarcinoma: a phase II study.
Biran H; Sulkes A; Biran S
Cancer Treat Rep; 1981; 65(9-10):924-5. PubMed ID: 7273031
[No Abstract] [Full Text] [Related]
2. Phase II trial: mitomycin c and methotrexate combination therapy for advanced colorectal carcinoma.
Budman DR; Schulman P; Vinciguerra V; Degnan T
Cancer Treat Rep; 1981; 65(5-6):535. PubMed ID: 7237477
[No Abstract] [Full Text] [Related]
3. Adriamycin, mitomycin C, and 5-fluorouracil in combination for advanced colorectal adenocarcinoma previously treated with 5-fluorouracil.
Kessinger MA; Foley JF; Lemon HM
Cancer Clin Trials; 1979; 2(4):317-9. PubMed ID: 394867
[TBL] [Abstract][Full Text] [Related]
4. Phase II study of mitomycin C, cyclophosphamide, and methotrexate in drug-resistant colorectal carcinoma.
Presant CA; Ratkin G; Klahr C
Cancer Treat Rep; 1978 Apr; 62(4):549-50. PubMed ID: 350389
[No Abstract] [Full Text] [Related]
5. Phase II trial of 5-fluorouracil, adriamycin, and mitomycin C in advanced colorectal cancer.
Haller DG; Woolley PV; Macdonald JS; Smith LF; Schein PS
Cancer Treat Rep; 1978 Apr; 62(4):563-5. PubMed ID: 350394
[TBL] [Abstract][Full Text] [Related]
6. Mitomycin and methotrexate: negative experience in untreated colorectal carcinoma.
Wernz JC; Kao AK; Muggia FM; Asbury RF
Cancer Treat Rep; 1985 Feb; 69(2):223-4. PubMed ID: 3918793
[No Abstract] [Full Text] [Related]
7. Phase II study of sequential methotrexate and 5-FU combination in the treatment of advanced colorectal cancer.
Canobbio L; Nobile MT; Ardizzoni A; Tatarek R; Rosso R
Cancer Treat Rep; 1986 Mar; 70(3):419-20. PubMed ID: 3955557
[No Abstract] [Full Text] [Related]
8. Phase II study of mitomycin, methotrexate, and vincristine combination chemotherapy in advanced adenocarcinoma of the lung.
Shah A; Klimo P; Murray N
Cancer Treat Rep; 1984 Oct; 68(10):1299-300. PubMed ID: 6525603
[No Abstract] [Full Text] [Related]
9. Phase II study of sequential methotrexate-5-FU therapy in advanced measurable colorectal cancer.
Cantrell JE; Brunet R; Lagarde C; Schein PS; Smith FP
Cancer Treat Rep; 1982 Jul; 66(7):1563-5. PubMed ID: 7093972
[TBL] [Abstract][Full Text] [Related]
10. Chemotherapy for colorectal cancer with a combination of 5-fluorouracil, mitomycin C, adriamycin, and cytosine arabinoside: a pilot study.
Davis S; Park YK
Cancer Treat Rep; 1978 Oct; 62(10):1557-9. PubMed ID: 709556
[TBL] [Abstract][Full Text] [Related]
11. Phase II trial of 5-FU melphalan in advanced colorectal carcinoma.
Gough IR; Furnival CM; Thynne GS; Burnett W
Cancer Treat Rep; 1981; 65(7-8):735-6. PubMed ID: 7248993
[No Abstract] [Full Text] [Related]
12. [Chemotherapy of gastrointestinal cancer in the advanced stage with a combination of 5-fluorouracil, adriamycin, mitomycin C (FAM). A non-controlled study].
Grieco A; Lasorella A; Astone A; Vagliviello L; Bartoloni C; Barone C
Clin Ter; 1984 Aug; 110(4):353-8. PubMed ID: 6237871
[No Abstract] [Full Text] [Related]
13. Effectiveness of intermediate-dose methotrexate and high-dose 5-fluorouracil as sequential combination chemotherapy in refractory breast cancer and as primary therapy in metastatic adenocarcinoma of the colon.
Tisman G; Wu SJ
Cancer Treat Rep; 1980; 64(8-9):829-35. PubMed ID: 7448820
[TBL] [Abstract][Full Text] [Related]
14. [A clinical study (phase II) of a combination of 5-fluorouracil, vincristine and methyl CCNU in patients with advanced carcinoma of the large intestine].
Roth A; Kolarić K
Lijec Vjesn; 1983 Jun; 105(6):244-6. PubMed ID: 6633141
[No Abstract] [Full Text] [Related]
15. Melphalan, vincristine, and 5-FU in advanced colonic carcinoma: results of a pilot study.
Ashenhurst J; Bitran JD; Robin E; Desser RK; Shapiro C; Kozloff MF; Billings AA
Cancer Treat Rep; 1981; 65(9-10):869-72. PubMed ID: 7273020
[TBL] [Abstract][Full Text] [Related]
16. Phase II trial of oral methotrexate and dipyridamole in colorectal carcinoma.
Wadler S; Subar M; Green MD; Wiernik PH; Muggia FM
Cancer Treat Rep; 1987 Sep; 71(9):821-4. PubMed ID: 3621214
[TBL] [Abstract][Full Text] [Related]
17. Phase II study of 5-FU, doxorubicin, and mitomycin (FAM) and chlorozotocin in advanced measureable pancreatic cancer.
Smith FP; Rustgi VK; Schertz G; Woolley PV; Schein PS
Cancer Treat Rep; 1982 Dec; 66(12):2095-6. PubMed ID: 6215982
[No Abstract] [Full Text] [Related]
18. Combination chemotherapy with 5-FU 1-(aminomethyl)-3-(2-chloroethyl)-3-nitrosourea (ACNU), and mitomycin (FUM) for carcinoma of the pancreas.
Meguro S; Kuraishi Y; Ichiba K; Abe M; Yoda T; Mikouchi S
Cancer Treat Rep; 1982 Aug; 66(8):1645-6. PubMed ID: 6955023
[No Abstract] [Full Text] [Related]
19. Phase II trial of streptozotocin, mitomycin C, and 5-fluorouracil in adenocarcinoma of the pancreas.
Bukowski RM; Abderhalden RT; Hewlett JS; Weick JK; Groppe CW
Cancer Clin Trials; 1980; 3(4):321-4. PubMed ID: 6448716
[TBL] [Abstract][Full Text] [Related]
20. Phase II trial of 5-fluorouracil plus melphalan in colorectal carcinoma.
Presant CA; Ratkin G; Klahr C
Cancer Treat Rep; 1978 Mar; 62(3):461-2. PubMed ID: 348317
[No Abstract] [Full Text] [Related]
[Next] [New Search]
